v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows used in operating activities:    
Net loss $ (5,267,203) $ (7,133,196)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 244,106 255,695
Stock based compensation 217,326 342,791
Amortization of right-of-use operating lease asset 219,263 209,740
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 426,050 418,718
Accounts payable and other current liabilities (745,834) (302,096)
Due to related parties (341,719) 235,465
Net cash used in operating activities (5,248,011) (5,972,883)
Cash used in investing activities    
Purchases of property and equipment (1,653) (2,192)
Net cash used investing activities (1,653) (2,192)
Cash flows provided by financing activities:    
Proceeds from the issuance of common stock, pre-funded warrants and warrant exercises 7,749,942 5,384,307
Payments for deferred offering costs related to equity issuances (1,021,602) 0
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units (9,940) (15,983)
Net cash provided by financing activities 6,718,400 5,368,324
Effect of exchange rate on changes on cash (12,704) (9,840)
Net increase (decrease) in cash, cash equivalents and restricted cash 1,456,032 (616,591)
Cash, cash equivalents and restricted cash at beginning of period 5,599,074 5,529,484
Cash, cash equivalents and restricted cash 7,055,106 4,912,893
Supplemental disclosures of non-cash investing and financing activities:    
Par value of shares issued for vested restricted stock units 4 0
Warrant modification costs 135,676 0
Deferred offering costs not yet paid 124,507 34
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 6,956,397 4,825,387
Restricted cash $ 98,709 $ 87,506

Source

10-Q PDF
XBRL